Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair

NCT07380932 is registered in ClinicalTrials.gov with Atrial Fibrillation Network as lead sponsor.

NCT NCT07380932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07380932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair
Lead sponsor
Atrial Fibrillation Network
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 31, 2032
Enrollment
956 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), mitral valve (mv) regurgitation